Alyeska Investment Group, L.P. Bionano Genomics, Inc. Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Bionano Genomics, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,326,000 shares of BNGO stock, worth $304,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,326,000Holding current value
$304,980% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNGO
# of Institutions
4Shares Held
4.97KCall Options Held
0Put Options Held
0About Bionano Genomics, Inc.
- Ticker BNGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 290,140,000
- Market Cap $66.7M
- Description
- Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...